3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activity-Reference-Cited by-同舟云学术

3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activity

Published:2015-05 Issue: Volume:95 Page:349-356
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Hudkins Robert L.,Becknell Nadine C.,Lyons Jacquelyn A.,Aimone Lisa D.,Olsen Mark,Haltiwanger R. Curtis,Mathiasen Joanne R.,Raddatz Rita,Gruner John A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference34 articles.

1. Recent advances in drug discovery of histamine H3 antagonist;Hudkins;Annu. Rep. Med. Chem.,2007

2. Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases;Raddatz;Curr. Top. Med. Chem.,2010

3. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders;Passani;Trends Pharm. Sci.,2004

4. Histamine H3 receptor as a drug discovery target;Berlin;J. Med. Chem.,2011

5. Histamine H3 receptor antagonists go to Clinics;Sander;Biol. Pharm. Bull.,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-targeting Approach on Histamine H3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders;Current Medicinal Chemistry;2021-05-31

2. Histamine H3 receptor antagonists/inverse agonists: Where do they go?;Pharmacology & Therapeutics;2019-08

3. Central nervous system effects of the histamine‐3 receptor antagonist CEP‐26401, in comparison with modafinil and donepezil, after a single dose in a cross‐over study in healthy volunteers;British Journal of Clinical Pharmacology;2019-03-14

4. 6,7-Dimorpholinoalkoxy quinazoline derivatives as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells;European Journal of Medicinal Chemistry;2018-03

5. The therapeutic journey of pyridazinone;European Journal of Medicinal Chemistry;2016-11